Orphanet journal of rare diseases
Methodological challenges in Dutch HTA of non-oncological orphan drugs: a retrospective analysis and price comparison using different pricing models.
Jelle Walraven, Mahtab Kaveh, Carin Uyl-de Groot
Published: 202610.1186/s13023-025-04181-6
No abstract available for this study.